Sana Biotechnology
(NASDAQ) SANA
Sana Biotechnology Financials at a Glance
Market Cap
$853.97M
Revenue (TTM)
$0.00
Net Income (TTM)
$244.17M
EPS (TTM)
$-0.98
P/E Ratio
-3.28
Dividend
$0.00
Beta (Volatility)
2.10 (High)
Dividend
$0.00
Beta (Volatility)
2.10 (High)
Price
$3.21
Volume
80,586
Open
$2.91
Price
$3.21
Volume
80,586
Open
$2.91
Previous Close
$3.21
Daily Range
$2.88 - $3.21
52-Week Range
$1.26 - $6.55
Dividend
$0.00
Beta (Volatility)
2.10 (High)
Price
$3.21
Volume
80,586
Open
$2.91
Previous Close
$3.21
Daily Range
$2.88 - $3.21
52-Week Range
$1.26 - $6.55
SANA News
SANA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sana Biotechnology
Industry
Biotechnology
Sector
Health CareEmployees
142
CEO
Steven D. Harr, MD
Website
www.sana.comHeadquarters
Seattle, WA 98102, US
SANA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-119%
Return on Capital
-56%
Return on Assets
-59%
Earnings Yield
-30.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$853.97M
Shares Outstanding
266.87M
Volume
80.59K
Short Interest
0.00%
Avg. Volume
2.61M
Financials (TTM)
Gross Profit
$12.75M
Operating Income
$190.96M
EBITDA
$178.21M
Operating Cash Flow
$143.83M
Capital Expenditure
$938.00K
Free Cash Flow
$144.77M
Cash & ST Invst.
$138.38M
Total Debt
$78.86M
Sana Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$3.05M
N/A
Gross Margin
0.00%
N/A
Market Cap
$853.97M
N/A
Market Cap/Employee
$4.40M
N/A
Employees
194
N/A
Net Income
$58.83M
-19.9%
EBITDA
$49.57M
-9.7%
Quarterly Fundamentals
Net Cash
$59.52M
+2.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$63.92M
-21.7%
Short Term Debt
$14.94M
+19.2%
Return on Assets
-58.57%
N/A
Return on Invested Capital
-56.47%
N/A
Free Cash Flow
$33.51M
+29.6%
Operating Cash Flow
$32.64M
+30.8%